STAT+: Newer GLP-1s, pushback on research cuts, and a protest

STAT PlusHealth Newer GLP-1s, pushback on research cuts, and a protest You’re reading the web edition of STAT’s ADA in 30 Seconds Manage alerts for this article Email this article Share this article By Elizabeth CooneyJune 5, 2026 Cardiovascular Disease Reporter Elizabeth Cooney[email protected]Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. You’re reading the web edition of STAT’s ADA in 30 Seconds newsletter from the American Diabetes Association’s annual conference. Sign up here This is Elizabeth Cooney saying hello from New Orleans, where the weather is warm, the conference center is cool, and debates can be fiery. Welcome to the first of three ADA in 30 newsletters, in which my colleague Elaine Chen and I curate some of the news and analyses circulating here near the banks of the mighty Mississippi. First up, thoughts from Rick Woychik, a senior adviser to NIH chief Jay Bhattacharya who subbed for him as keynote speaker, plus some background from our STAT colleague Anil Oza. Then, what the weekend will bring.Advertisement If you are here too, come say Hi, or reach me at [email protected]. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In chronic disease, diabetes, STAT+ Submit a correction requestReprints Elizabeth Cooney Cardiovascular Disease Reporter Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Newsletter Stay on top of the latest developments coming out of the American Diabetes Association conference. Recommended Politics June 5, 2026 STAT Plus: What stripping civil service protections for thousands of federal workers will mean for HHS Politics June 5, 2026 Senior NIH official pushes MAHA strategy to skeptical ADA audience Advertisement First Opinion June 5, 2026 If Americans risk their lives fighting Ebola overseas, they deserve the right to come home The Readout June 5, 2026 STAT Plus: Will Makary’s FDA voucher program survive? Pharmalot June 5, 2026 STAT Plus: Up and down the ladder: The latest comings and goings Subscriber Picks